GC31669
Lusutrombopag
Also listed as Lusutrombopag (S-888711)
Lusutrombopag, an orally bioavailable, small molecule thrombopoietin receptor agonist, is approved for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure
ChemicalCAS1110766-97-6MW591.55FormulaC29H32Cl2N2O5S
- CAS number
- 1110766-97-6
- Molecular weight
- 591.55
- Formula
- C29H32Cl2N2O5S
- Solubility
- DMSO ： ≥ 33 mg/mL (55·79 mM)
- InChIKey
- NOZIJMHMKORZBA-KJCUYJGMSA-N
- Catalogue number
- GC31669
- Brand
- GLPBIO
Computed properties PubChem CID 49843517 · XLogP 7.7 · TPSA 126 Ų · H-bond donors 2
- XLogP
- 7.7
- TPSA
- 126 Ų
- H-bond donors
- 2
- H-bond acceptors
- 7
- Rotatable bonds
- 13
- Heavy atoms
- 39
SMILES CCCCCCO[C@@H](C)C1=CC=CC(=C1OC)C2=CSC(=N2)NC(=O)C3=CC(=C(C(=C3)Cl)/C=C(\C)/C(=O)O)Cl
Computed descriptors from PubChem (CID 49843517), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il